An international research group led by Charit Universit tsmedizin Berlin has successfully completed the phase 3 and final testing of a new drug that could possibly treat rheumatoid arthritis. While there s no cure for the disease medication and physiotherapy are the types of treatments available to slow down the progression and manage the problems associated with rheumatoid arthritis. The research paper published in the journal The Lancet concluded that the new drug has a positive effect on the patients with moderate to severe forms of the disease who have shown an inadequate response to conventional disease-modifying drugs. Rheumatoid arthritis
